Sabatos-Peyton, Catherine A.
2 papers on CoChat
Most cited papers
- Verified
Phase I/Ib Clinical Trial of Sabatolimab, an Anti‐TIM‐3 Antibody, Alone and in Combination with Spartalizumab, an Anti‐PD‐1 Antibody, in Advanced Solid Tumors
Curigliano, G., Gelderblom, H., Mach, N., Doi, T., Tai, D., Forde, P. M., Sarantopoulos, J., Bedard, P. L., Lin, C.-C., Hodi, F. S., et al. (2021) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 362
- Verified
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Bonazzi, S., d’Hennezel, E., Beckwith, R. E. J., Xu, L., Fazal, A., Magracheva, A., Ramesh, R., Cernijenko, A., Antonakos, B., Bhang, H.-E. C., et al. (2023) · Cell Chemical Biology
Protein Degradation and InhibitorsCancer Immunotherapy and Biomarkers
Cited by 167
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free